Trending >

Telus buys electronic medical records firm KinLogix

Canadian telecom Telus (TSX:T) Wednesday acquired Quebec-based KinLogix, a provider of electronic medical records.

The financial terms of the deal were not disclosed.

KinLogix provides a cloud-based system to capture, organize and display patient data in one record.

Founded in 2000 by Dr. Michel Hébert, KinLogix is the largest and fastest-growing electronic medical records player in Quebec, representing 36 per cent of the province’s electronic medical records market.

The solutions are deployed in more than 200 medical clinics and represents 36 per cent of Quebec’s electronic medical records market.

“By acquiring KinLogix, Telus is delivering on its national strategy, which will further the adoption of EMRs, an essential building block to an efficient health-care system in Canada,” said Telus Health senior vice-president Paul Lepage.

“Combined with Telus’s expertise and technology, the KinLogix EMR has the ability to share information electronically between physicians and patients, ultimately facilitating enhancement of care delivery and improvement of health-care efficiency, thereby positively affecting the lives of Canadians.”

The KinLogix team will join the Telus Physician Solutions group and Dr. Michel Hébert will assume the role of Medical Director reporting to Dr. Brendan Byrne, VP of Telus Physician Solutions.

Joyanta Acharjee
Proactive Investors
Source Article Here

  •  
  •  
  •  

About The Author /

Nick Waddell
Cantech Letter founder and editor Nick Waddell has lived in five Canadian provinces and is proud of his country's often overlooked contributions to the world of science and technology. Waddell takes a regular shift on the Canadian media circuit, making appearances on CTV, CBC and BNN, and contributing to publications such as Canadian Business and Business Insider.

Comment

Leave a Reply

Your email address will not be published. Required fields are marked *

Access Expert Stock Picks for free

CLOSE

Get Stock Picks From The Pros

Sign up for our newsletter to get timely Canadian stock picks from expert financial analysts.